Back to search
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation trials you may qualify forThe purpose of this study was to determine the clinical benefit of ASP2215 therapy in participants with FMS-like tyrosine kinase (FLT3) mutated AML who were ref…
Quizartinib is an experimental drug. It is not approved for regular use. It can only be used in medical research. Children or young adults with a certain kind…